2024 Q3 Form 10-K Financial Statement

#000165495424012491 Filed on September 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2024
Revenue $5.756M $24.57M
YoY Change -6.04% -15.9%
Cost Of Revenue $4.239M $18.05M
YoY Change -8.7% -18.06%
Gross Profit $1.517M $6.526M
YoY Change 2.29% -9.26%
Gross Profit Margin 26.36% 26.56%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $42.59K $156.6K
YoY Change 30.17% 16.34%
% of Gross Profit 2.81% 2.4%
Depreciation & Amortization $109.2K $412.2K
YoY Change 10.08% 16.49%
% of Gross Profit 7.2% 6.32%
Operating Expenses $1.639M $6.352M
YoY Change 8.18% 12.46%
Operating Profit -$122.0K $174.0K
YoY Change 281.25% -88.73%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$411.0K
YoY Change 15.77%
Pretax Income -$210.0K -$237.0K
YoY Change 66.67% -119.93%
Income Tax $0.00 $162.0K
% Of Pretax Income
Net Earnings -$210.0K -$399.0K
YoY Change 66.67% -133.28%
Net Earnings / Revenue -3.65% -1.62%
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 76.64M shares 76.55M shares 76.55M shares
Diluted Shares Outstanding 76.83M shares 76.55M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.068M $1.028M
Short-Term Investments
Other Short-Term Assets $171.0K $141.0K
YoY Change 40.16% 67.86%
Inventory $3.004M $3.287M
Prepaid Expenses
Receivables $1.198M $1.061M
Other Receivables
Total Short-Term Assets $5.441M $5.517M
YoY Change -16.09% -13.5%
LONG-TERM ASSETS
Property, Plant & Equipment $1.762M $1.870M
YoY Change -17.74% -14.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.371M $3.614M
YoY Change -17.15% -14.62%
TOTAL ASSETS
Total Short-Term Assets $5.441M $5.517M
Total Long-Term Assets $3.371M $3.614M
Total Assets $8.812M $9.131M
YoY Change -16.5% -13.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.435M $1.502M
YoY Change -34.11% -28.95%
Accrued Expenses $686.0K $508.0K
YoY Change 21.42% 22.12%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.547M $4.177M
YoY Change -2.55% -8.9%
LONG-TERM LIABILITIES
Long-Term Debt $534.0K $854.0K
YoY Change -57.38% -25.61%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.637M $2.124M
YoY Change -41.74% -24.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.547M $4.177M
Total Long-Term Liabilities $1.637M $2.124M
Total Liabilities $6.183M $6.301M
YoY Change -17.3% -14.85%
SHAREHOLDERS EQUITY
Retained Earnings -$4.398M -$4.188M
YoY Change 12.31% 10.5%
Common Stock $766.0K $765.0K
YoY Change 0.13% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.629M $2.830M
YoY Change
Total Liabilities & Shareholders Equity $8.812M $9.131M
YoY Change -16.5% -13.95%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2024
OPERATING ACTIVITIES
Net Income -$210.0K -$399.0K
YoY Change 66.67% -133.28%
Depreciation, Depletion And Amortization $109.2K $412.2K
YoY Change 10.08% 16.49%
Cash From Operating Activities $132.0K $475.0K
YoY Change -23.26% -28.14%
INVESTING ACTIVITIES
Capital Expenditures $1.000K $71.00K
YoY Change -96.88% -38.26%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.000K -$71.00K
YoY Change -96.88% -38.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$91.00K -$417.0K
YoY Change 111.63% 14.56%
NET CHANGE
Cash From Operating Activities $132.0K $475.0K
Cash From Investing Activities -$1.000K -$71.00K
Cash From Financing Activities -$91.00K -$417.0K
Net Change In Cash $40.00K -$13.00K
YoY Change -58.76% -107.14%
FREE CASH FLOW
Cash From Operating Activities $132.0K $475.0K
Capital Expenditures $1.000K $71.00K
Free Cash Flow $131.0K $404.0K
YoY Change -6.43% -26.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001374567
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5700000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76547672 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76547672 shares
CY2024 luvu Weighted Average Exercise Price Outstanding Begining Balance
WeightedAverageExercisePriceOutstandingBeginingBalance
0.14
CY2024Q2 luvu Shares Of Common Stock Reserved For Issuance Under The2015 Stock Option Plan
SharesOfCommonStockReservedForIssuanceUnderThe2015StockOptionPlan
1700000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2023 luvu Stock Issued During Period Share Stocks Options Exercised
StockIssuedDuringPeriodShareStocksOptionsExercised
501423 shares
CY2023Q4 us-gaap Income Tax Examination Penalties Accrued
IncomeTaxExaminationPenaltiesAccrued
125000 usd
CY2024 luvu Increase Decrease In Income Tax Penalties And Interest
IncreaseDecreaseInIncomeTaxPenaltiesAndInterest
38000 usd
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
000-53314
CY2024 dei Entity Registrant Name
EntityRegistrantName
Luvu Brands, Inc.
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-3581576
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
2745 Bankers Industrial Drive
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30360
CY2024 dei City Area Code
CityAreaCode
770
CY2024 dei Local Phone Number
LocalPhoneNumber
246-6400
CY2024 dei Security12g Title
Security12gTitle
Common Stock, $.01 par value
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Public Float
EntityPublicFloat
6123814 usd
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
76642628 shares
CY2024 dei Auditor Firm
AuditorFirmId
287
CY2024 dei Auditor Location
AuditorLocation
Atlanta, Georgia
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1028000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1041000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1061000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1051000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
3287000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
4202000 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
141000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
83000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
5517000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
6377000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1870000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2187000 usd
CY2024Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
103000 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
24000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1545000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1913000 usd
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 usd
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10000 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
96000 usd
CY2023Q2 us-gaap Other Assets
OtherAssets
100000 usd
CY2024Q2 us-gaap Assets
Assets
9131000 usd
CY2023Q2 us-gaap Assets
Assets
10611000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1502000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2114000 usd
CY2024Q2 us-gaap Debt Current
DebtCurrent
1639000 usd
CY2023Q2 us-gaap Debt Current
DebtCurrent
1659000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
508000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
416000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
528000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
396000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4177000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4585000 usd
CY2024Q2 luvu Deferred Tax Liabilities Noncurrents
DeferredTaxLiabilitiesNoncurrents
119000 usd
CY2023Q2 luvu Deferred Tax Liabilities Noncurrents
DeferredTaxLiabilitiesNoncurrents
0 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
854000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1148000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1151000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1667000 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2124000 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2815000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
6301000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
7400000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5700000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
765000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
765000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6253000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6234000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4188000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3790000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2830000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3211000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9131000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10611000 usd
CY2024 us-gaap Revenues
Revenues
24574000 usd
CY2023 us-gaap Revenues
Revenues
29219000 usd
CY2024 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18048000 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22027000 usd
CY2024 us-gaap Gross Profit
GrossProfit
6526000 usd
CY2023 us-gaap Gross Profit
GrossProfit
7192000 usd
CY2024 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1028000 usd
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
791000 usd
CY2024 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
1725000 usd
CY2023 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
1422000 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3187000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3081000 usd
CY2024 us-gaap Depreciation
Depreciation
412000 usd
CY2023 us-gaap Depreciation
Depreciation
354000 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
6352000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
5648000 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
174000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
1544000 usd
CY2024 us-gaap Financing Interest Expense
FinancingInterestExpense
411000 usd
CY2023 us-gaap Financing Interest Expense
FinancingInterestExpense
355000 usd
CY2024 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-411000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-355000 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-237000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1189000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
162000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-399000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
1199000 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76547672 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76333485 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76547672 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76494717 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1956000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
46000 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
1199000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3211000 usd
CY2024 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
19000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-399000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2830000 usd
CY2024 us-gaap Profit Loss
ProfitLoss
399000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
1199000 usd
CY2024 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
129000 usd
CY2023 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-10000 usd
CY2024 us-gaap Depreciation And Amortization
DepreciationAndAmortization
412000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
354000 usd
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
19000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
46000 usd
CY2024 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
10000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1000 usd
CY2024 luvu Provision For Inventory Reserve
ProvisionForInventoryReserve
-38000 usd
CY2023 luvu Provision For Inventory Reserve
ProvisionForInventoryReserve
76000 usd
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-54000 usd
CY2024 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-953000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
460000 usd
CY2024 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
54000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-81000 usd
CY2024 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-615000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-566000 usd
CY2024 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
52000 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-77000 usd
CY2024 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
40000 usd
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-42000 usd
CY2024 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-383000 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-337000 usd
CY2024 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
369000 usd
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
342000 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
475000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
661000 usd
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
71000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
115000 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-71000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-115000 usd
CY2024 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
5000 usd
CY2023 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-31000 usd
CY2024 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
13000 usd
CY2023 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
12000 usd
CY2024 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
0 usd
CY2023 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
200000 usd
CY2024 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
200000 usd
CY2024 luvu Payments On Equipment Notes
PaymentsOnEquipmentNotes
392000 usd
CY2023 luvu Payments On Equipment Notes
PaymentsOnEquipmentNotes
308000 usd
CY2024 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2000 usd
CY2024 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
17000 usd
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
15000 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-417000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-364000 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-13000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
182000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1041000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
859000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1028000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1041000 usd
CY2024 us-gaap Notes Issued1
NotesIssued1
0 usd
CY2023 us-gaap Notes Issued1
NotesIssued1
414000 usd
CY2024 luvu Finance Lease Asset Obligation In Exchange For Lease Payable
FinanceLeaseAssetObligationInExchangeForLeasePayable
104000 usd
CY2023 luvu Finance Lease Asset Obligation In Exchange For Lease Payable
FinanceLeaseAssetObligationInExchangeForLeasePayable
0 usd
CY2024 luvu Finance Lease Asset Obligation In Exchange For Lease Payables Two
FinanceLeaseAssetObligationInExchangeForLeasePayablesTwo
0 usd
CY2023 luvu Finance Lease Asset Obligation In Exchange For Lease Payables Two
FinanceLeaseAssetObligationInExchangeForLeasePayablesTwo
0 usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
363000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
350000 usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q2 luvu Allowance For Discounts And Returns
AllowanceForDiscountsAndReturns
55000 usd
CY2024Q2 luvu Fdic Balance Limit Excess
FdicBalanceLimitExcess
835054 usd
CY2024 us-gaap Increase Decrease In Prepaid Advertising
IncreaseDecreaseInPrepaidAdvertising
836 usd
CY2023 us-gaap Increase Decrease In Prepaid Advertising
IncreaseDecreaseInPrepaidAdvertising
0 usd
CY2024Q2 luvu Deferred Tax Assets Valuation Allowances
DeferredTaxAssetsValuationAllowances
1400000 usd
CY2024Q2 luvu Property Plant And Equipments Net
PropertyPlantAndEquipmentsNet
1973000 usd
CY2023Q2 luvu Property Plant And Equipments Net
PropertyPlantAndEquipmentsNet
2186000 usd
CY2024Q2 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
371000 usd
CY2024Q2 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
292000 usd
CY2024Q2 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
122000 usd
CY2024Q2 luvu Contractual Obligation Duesixth Year
ContractualObligationDuesixthYear
38000 usd
CY2024Q2 luvu Other Note Payable Current
OtherNotePayableCurrent
-371000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
1700000 shares
CY2024Q2 luvu Number Of Shares Available For Issuance Under Plan
NumberOfSharesAvailableForIssuanceUnderPlan
350000 shares
CY2023 luvu Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumberbegining Balance
SharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumberbeginingBalance
1975000 shares
CY2023 luvu Weighted Average Exercise Price Outstanding Begining Balance
WeightedAverageExercisePriceOutstandingBeginingBalance
0.10
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
107500 usd
CY2023 luvu Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod
525000 shares
CY2023 luvu Weighted Average Exercise Price Exercised
WeightedAverageExercisePriceExercised
0.03
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
50000 shares
CY2023 luvu Weighted Average Exercise Price Forfeited Expired
WeightedAverageExercisePriceForfeitedExpired
0.03
CY2023 luvu Weighted Average Exercise Price Outstanding Ending Balance
WeightedAverageExercisePriceOutstandingEndingBalance
0.14
CY2023 luvu Weighted Average Remaining Contractual Life Ending
WeightedAverageRemainingContractualLifeEnding
P3Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
29000 usd
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
450000 shares
CY2024 luvu Weighted Average Exercise Price Forfeited Expired
WeightedAverageExercisePriceForfeitedExpired
0.15
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
21000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
812500 shares
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
21000 usd
CY2024Q2 us-gaap Share Price
SharePrice
0.08
CY2022Q2 us-gaap Share Price
SharePrice
0.14
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.08
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0 pure
CY2024 luvu Share Based Compensation Arrangements By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2024 luvu Forfeiture Rate
ForfeitureRate
0 pure
CY2023 luvu Forfeiture Rate
ForfeitureRate
0 pure
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P4Y1M6D
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q2 luvu Proceeds From Stock Exercise
ProceedsFromStockExercise
2100 usd
CY2024Q2 luvu Unrecognized Stock Expense
UnrecognizedStockExpense
66851 usd
CY2024 luvu Weighted Average Vesting Period Term
WeightedAverageVestingPeriodTerm
P2Y2M12D
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000 shares
CY2024Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
55000 usd
CY2023Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
65000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
3000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
5000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
23000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
41000 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1354000 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1041000 usd
CY2024Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1435000 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1152000 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1435000 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1059000 usd
CY2024Q2 luvu Preconfirmations Deferred Income Tax Liabilities Current
PreconfirmationsDeferredIncomeTaxLiabilitiesCurrent
-119000 usd
CY2023Q2 luvu Preconfirmations Deferred Income Tax Liabilities Current
PreconfirmationsDeferredIncomeTaxLiabilitiesCurrent
-83000 usd
CY2024Q2 luvu Deferred Tax Assets Net Assets And Liability
DeferredTaxAssetsNetAssetsAndLiability
-119000 usd
CY2023Q2 luvu Deferred Tax Assets Net Assets And Liability
DeferredTaxAssetsNetAssetsAndLiability
10000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
0.2575 pure
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-50000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
250000 usd
CY2024 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-11000 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
56000 usd
CY2024 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
16000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
1000 usd
CY2024 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-169000 usd
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
0 usd
CY2024 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
376000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-317000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
162000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10000 usd
CY2024 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
33000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2024 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
129000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
162000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10000 usd
CY2024Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
5300000 usd
CY2024 luvu Valuation Allowance Deferred Tax Asset Change In Amount One
ValuationAllowanceDeferredTaxAssetChangeInAmountOne
376000 usd
CY2023 luvu Valuation Allowance Deferred Tax Asset Change In Amount One
ValuationAllowanceDeferredTaxAssetChangeInAmountOne
-317000 usd
CY2024 luvu Income Tax Reconciliation Loss Income Forward Rate
IncomeTaxReconciliationLossIncomeForwardRate
0.80 pure
CY2024 dei Auditor Name
AuditorName
EC Barrett, LLC

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001654954-24-012491-index-headers.html Edgar Link pending
0001654954-24-012491-index.html Edgar Link pending
0001654954-24-012491.txt Edgar Link pending
0001654954-24-012491-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
luvu-20240630.xsd Edgar Link pending
luvu_10k.htm Edgar Link pending
luvu_10kimg2.jpg Edgar Link pending
luvu_10kimg3.jpg Edgar Link pending
luvu_10kimg5.jpg Edgar Link pending
luvu_10kimg6.jpg Edgar Link pending
luvu_ex141.htm Edgar Link pending
luvu_ex311.htm Edgar Link pending
luvu_ex312.htm Edgar Link pending
luvu_ex321.htm Edgar Link pending
luvu_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
luvu-20240630_cal.xml Edgar Link unprocessable
luvu-20240630_def.xml Edgar Link unprocessable
luvu-20240630_lab.xml Edgar Link unprocessable
luvu-20240630_pre.xml Edgar Link unprocessable
luvu_10k_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending